Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MULTIHANCE vs MUROMONAB-CD3: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MULTIHANCE vs MUROMONAB-CD3: Safety Overview

Metric MULTIHANCE MUROMONAB-CD3
Total FAERS Reports 183 114
Deaths Reported 14 28
Death Rate 7.7% 24.6%
Hospitalizations 33 28
Average Patient Age 52.0 yrs 30.2 yrs
% Female Patients N/A 45.0%